Valuation: Azenta, Inc.

Market Cap 1.17B 1.02B 945M 873M 1.66B 112B 1.68B 11.29B 4.44B 55.05B 4.4B 4.3B 189B P/E 2026 *
-6.94x
P/E 2027 * 106x
Enterprise Value 1.17B 1.02B 945M 873M 1.66B 112B 1.68B 11.29B 4.44B 55.05B 4.4B 4.3B 189B EV / Sales 2026 *
1.95x
EV / Sales 2027 * 1.86x
Free-Float
76.62%
Yield 2026 *
-
Yield 2027 * -
1 day-0.41%
1 week-1.32%
Current month-0.74%
1 month+13.18%
3 months+14.05%
6 months-32.53%
Current year-23.84%
1 week 24.24
Extreme 24.245
26.04
1 month 21.77
Extreme 21.77
27.05
Current year 15.93
Extreme 15.93
41.73
1 year 15.93
Extreme 15.93
41.73
3 years 15.93
Extreme 15.93
69.16
5 years 15.93
Extreme 15.93
124.79
10 years 11.58
Extreme 11.58
124.79
Manager TitleAgeSince
Chief Executive Officer 45 2024-09-08
Director of Finance/CFO 49 2024-11-30
Chief Tech/Sci/R&D Officer - 2009-10-31
Director TitleAgeSince
Director/Board Member 64 2013-06-27
Director/Board Member 50 2020-04-02
Chairman 72 2024-01-29
Date Insider Type Main position Quantity % Market Cap.
May. 17Buy

Director

10,000 0.0217%
May. 14Tax

General Counsel

-3,621 0.0079%
Apr. 27Free

President Multiomics

17,790 0.0386%
Change 5-day change 1-year change 3-year change Capi.($)
-0.41%-1.32%-25.83%-47.20% 1.17B
+0.58%+2.06%+2.92%+10.86% 50.44B
-1.89%-1.58%+385.68%+587.19% 40.63B
-0.69%+0.77%+25.39%-5.41% 34.88B
-1.51%-3.54%+17.80%+55.04% 33.67B
+1.21%-0.79%+4.46%+35.18% 26.29B
-2.06%+0.06% - - 17.11B
+0.12%-5.47%+62.80%+121.01% 15.29B
-7.73%-29.32%+38.73%+40.73% 10.62B
+0.23%-0.58%+13.76%+21.11% 13.74B
Average -1.20%-2.55%+58.41%+90.95% 24.38B
Weighted average by Cap. -0.80%-0.06%+83.58%+130.17%

Financials

2026 *2027 *
Net sales 600M 525M 484M 447M 849M 57.27B 863M 5.79B 2.27B 28.21B 2.25B 2.21B 96.99B 630M 551M 508M 469M 890M 60.04B 905M 6.07B 2.38B 29.58B 2.36B 2.31B 102B
Net income -159M -139M -128M -119M -225M -15.18B -229M -1.53B -603M -7.48B -598M -585M -25.71B 17.3M 15.13M 13.96M 12.89M 24.46M 1.65B 24.87M 167M 65.49M 813M 64.96M 63.54M 2.79B
Net Debt - -
Logo Azenta, Inc.
Azenta, Inc. is a global provider of biological and chemical compound sample exploration and management solutions for the life sciences industry. The Company develops solutions for automated ultra-cold storage. It operates through two segments, which include Sample Management Solutions and Multiomics. The Sample Management Solutions segment operates as a single business unit offering end-to-end sample management products and services, including sample repository services and core products (automated stores, cryogenic systems, automated sample tube, consumables and instruments and controlled rate thawing devices). The Multiomics segment operates as a single business unit offering genomic and other sample analysis services, including gene sequencing, gene synthesis and related services. It offers a portfolio of products and sample services including procurement, automated storage systems, genomic services and a multitude of sample consumables, informatics and data software.
Employees
2,900
Date Price Change Volume
26-07-10 $25.33 -0.35% 153,692
26-07-09 $25.42 +3.71% 591,983
26-07-08 $24.51 -3.39% 556,520
26-07-07 $25.37 -1.17% 814,409
26-07-06 $25.67 -0.66% 526,910
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
25.42USD
Average target price
26.20USD
Spread / Average Target
+3.07%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. AZTA Stock